Cargando…
Economic Burden of HIV in a Commercially Insured Population in the United States
Background: With advances in antiretroviral therapy (ART), people with HIV infection are living longer. Pre-exposure prophylaxis (PrEP) to reduce HIV infection risk continues to be underutilized in high-risk individuals. Recent data on economic burden for patients with newly diagnosed HIV-1 or initi...
Autores principales: | Chen, Cindy Y., Donga, Prina, Campbell, Alicia K., Taiwo, Babafemi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Columbia Data Analytics, LLC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9865714/ https://www.ncbi.nlm.nih.gov/pubmed/36721765 http://dx.doi.org/10.36469/001c.56928 |
Ejemplares similares
-
Treatment and comorbidity burden among people living with HIV: a review of systematic literature reviews
por: Taiwo, Babafemi O., et al.
Publicado: (2022) -
Real-World Analysis of Weight Gain and Body Mass Index Increase Among Patients with HIV-1 Using Antiretroviral Regimen Containing Tenofovir Alafenamide, Tenofovir Disoproxil Fumarate, or Neither in the United States
por: Emond, Bruno, et al.
Publicado: (2022) -
Real-World Assessment of Weight Change in African American Females and Hispanics with HIV-1 After Initiating Integrase Strand-Transfer Inhibitors or Protease Inhibitors
por: Chen, Yen-Wen, et al.
Publicado: (2022) -
Weight Change and Predictors of Weight Change Among Patients Initiated on Darunavir/Cobicistat/Emtricitabine/Tenofovir Alafenamide or Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Real-World Retrospective Study
por: Emond, Bruno, et al.
Publicado: (2021) -
Testing for HIV infection in the emergency departments of 2 hospitals in the Southeastern United States
por: Safeek, Rachel, et al.
Publicado: (2020)